155 related articles for article (PubMed ID: 9569078)
1. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases.
Manna R; Latteri M; Cristiano G; Todaro L; Scuderi F; Gasbarrini G
Br J Rheumatol; 1998 Feb; 37(2):208-10. PubMed ID: 9569078
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
3. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL
Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica].
Hulin C; Hachulla E; Michon-Pasturel U; Hatron PY; Masy E; Gillot JM; Caron C; Arvieux J; Flipo RM; Devulder B
Rev Med Interne; 1999 Aug; 20(8):659-63. PubMed ID: 10480168
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
Berthelot JM; Lamour A; Mottier D; Pennec YL; Dueymes M; Jouquan J; Le Goff P; Youinou P
Ann Med Interne (Paris); 1992; 143(7):429-32. PubMed ID: 1300861
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin antibodies in the polymyalgia rheumatica-temporal arteritis syndromes.
McLean RM; Greco TP
Clin Rheumatol; 1995 Mar; 14(2):191-6. PubMed ID: 7789061
[TBL] [Abstract][Full Text] [Related]
8. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.
Baerlecken NT; Linnemann A; Gross WL; Moosig F; Vazquez-Rodriguez TR; Gonzalez-Gay MA; Martin J; Kötter I; Henes JC; Melchers I; Vaith P; Schmidt RE; Witte T
Ann Rheum Dis; 2012 Jun; 71(6):943-7. PubMed ID: 22228484
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes.
Duhaut P; Berruyer M; Pinede L; Demolombe-Rague S; Loire R; Seydoux D; Dechavanne M; Ninet J; Pasquier J
Arthritis Rheum; 1998 Apr; 41(4):701-9. PubMed ID: 9550480
[TBL] [Abstract][Full Text] [Related]
11. Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Hazleman B
Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S29-31. PubMed ID: 10948756
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica.
Große K; Schmidt RE; Witte T; Baerlecken NT
Scand J Rheumatol; 2013; 42(3):215-9. PubMed ID: 23682607
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica.
Schmits R; Kubuschok B; Schuster S; Preuss KD; Pfreundschuh M
Clin Exp Immunol; 2002 Feb; 127(2):379-85. PubMed ID: 11876765
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy.
Salvarani C; Macchioni P; Zizzi F; Mantovani W; Rossi F; Castri C; Capozzoli N; Baricchi R; Boiardi L; Chiaravalloti F
Arthritis Rheum; 1991 Mar; 34(3):351-6. PubMed ID: 2003856
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin (Gm) allotype frequencies in patients with giant bell arteritis and polymyalgia rheumatica.
Demaine AG; Vaughan RW; Behn AR; Myles AB; Panayi GS; Welsh KI
J Immunogenet; 1983 Oct; 10(5):343-8. PubMed ID: 6644068
[TBL] [Abstract][Full Text] [Related]
16. Polymyalgia rheumatica and giant cell arteritis: circulating immune complexes.
Espinoza LR; Bridgeford P; Lowenstein M; Bocanegra TS; Vasey FB; Germain BF
J Rheumatol; 1982; 9(4):556-60. PubMed ID: 6215486
[TBL] [Abstract][Full Text] [Related]
17. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
18. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions.
Gonzalez-Gay MA
Semin Arthritis Rheum; 2004 Apr; 33(5):289-93. PubMed ID: 15079759
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome.
Richardson JE; Gladman DD; Fam A; Keystone EC
Arthritis Rheum; 1987 Nov; 30(11):1293-7. PubMed ID: 3500727
[TBL] [Abstract][Full Text] [Related]
20. [Anticardiolipin antibodies and Horton disease].
Liozon F; Jauberteau-Marchan MO; Boutros-Toni F; Barrier JH; Dupond JL; Roblot P; Liozon E; Delaire L; Vidal E
Ann Med Interne (Paris); 1995; 146(8):541-7. PubMed ID: 8734078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
